Reported by Committee — Jul 29, 2015
Last Action: Ordered to be Reported by Voice Vote.
Explanation: The committees assigned to this bill sent it to the House or Senate as a whole for consideration on July 29, 2015.
Aug 10, 2010
111th Congress, 2009–2010
This bill was introduced on August 10, 2010, in a previous session of Congress, but was not enacted.
Representative for New Jersey's 4th congressional district
Read Text »
Last Updated: Aug 10, 2010
Length: 10 pages
Enacted — Signed by the President — Oct 8, 2010
Reported by Committee — Sep 23, 2010
To amend the Stem Cell Therapeutic and Research Act of 2005.
Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.
Reported by Committee
Last Action: Jul 29, 2015
Enacted — Signed by the President
Oct 8, 2010
The “H.R.” in “H.R. 6083” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The bill’s title was written by its sponsor.
The committee chair determines whether a bill will move past the committee stage.
There have been no votes related to this bill.
Search for similar bills.
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 6083 — 111th Congress: Stem Cell Therapeutic and Research Reauthorization Act of 2010. Retrieved from https://www.govtrack.us/congress/bills/111/hr6083
“H.R. 6083 — 111th Congress: Stem Cell Therapeutic and Research Reauthorization Act of 2010.” www.GovTrack.us. 2010. July 30, 2015 <https://www.govtrack.us/congress/bills/111/hr6083>
|title=H.R. 6083 (111th)
|accessdate=July 30, 2015
|author=111th Congress (2010)
|date=August 10, 2010
|quote=Stem Cell Therapeutic and Research Reauthorization Act of 2010